Trials / Conditions / Refractory Acute Leukemia of Ambiguous Lineage
Refractory Acute Leukemia of Ambiguous Lineage
4 registered clinical trials studyying Refractory Acute Leukemia of Ambiguous Lineage — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leuke NCT05761171 | Children's Oncology Group | Phase 2 |
| Active Not Recruiting | Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With NCT04898894 | St. Jude Children's Research Hospital | Phase 1 |
| Recruiting | CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatmen NCT04375631 | Fred Hutchinson Cancer Center | Phase 1 |
| Completed | High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory NCT02551718 | University of Washington | N/A |